Literature DB >> 23745803

Novel biomarkers assessing endothelial dysfunction: role of microRNAs.

Dimitris Tousoulis1, Emmanuel Androulakis, Nikolaos Papageorgiou, Gerasimos Siasos, George Latsios, Marietta Charakida, Anna-Maria Kampoli, Evangelos Oikonomou, Christodoulos Stefanadis.   

Abstract

Endothelial dysfunction reflected by reduced nitric oxide availability is nowadays considered as a causative factor of atherosclerosis. A variety of biomarkers has been used as indicators of endothelial dysfunction in cardiovascular disease. Discovered just over a decade ago, microRNAs have evoked a great deal of interest, due to their importance for many aspects of homeostasis and disease. miRNAs comprise a novel class of endogenous, single-stranded, short RNA sequences able to regulate gene expression by binding to complementary sequences on mRNAs According to a growing body of evidence, they have been implicated in the regulation of several human physiological processes. They have been shown to participate in cardiovascular disease pathogenesis including atherosclerosis and endothelial dysfunction and this may have important clinical implications.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23745803     DOI: 10.2174/15680266113139990100

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  2 in total

Review 1.  Flavonoids from fruit and vegetables: a focus on cardiovascular risk factors.

Authors:  J Y Toh; Verena M H Tan; Paul C Y Lim; S T Lim; Mary F F Chong
Journal:  Curr Atheroscler Rep       Date:  2013-12       Impact factor: 5.113

2.  Profiling the circulating miRNAs in mice exposed to gram-positive and gram-negative bacteria by Illumina small RNA deep sequencing.

Authors:  Cheng-Shyuan Rau; Shao-Chun Wu; Johnson Chia-Shen Yang; Tsu-Hsiang Lu; Yi-Chan Wu; Yi-Chun Chen; Siou-Ling Tzeng; Chia-Jung Wu; Ching-Hua Hsieh
Journal:  J Biomed Sci       Date:  2015-01-07       Impact factor: 8.410

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.